# Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease

> **NCT00113009** · PHASE2 · COMPLETED · sponsor: **Valentis** · enrollment: 148 (—)

## Conditions studied

- Peripheral Vascular Disease

## Interventions

- **DRUG:** VLTS-934

## Key facts

- **NCT ID:** NCT00113009
- **Lead sponsor:** Valentis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 148 (—)
- **Last updated:** 2007-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00113009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00113009, "Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00113009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*